Loading stock data…
Loading stock data…
US$19.52
Get one email when SPTX crosses your level. Checked every 15 minutes during market hours.
▼ -0.93 (-4.55%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
Healthcare · Biotechnology
Seaport Therapeutics, Inc. is a clinical-stage biotechnology company focused on inventing and developing novel oral medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company employs its proprietary Glyph platform to address limitations of clinically validated mechanisms, such as high first-pass metabolism, low bioavailability, and side effects, enabling innovative therapies with established efficacy and safety profiles. Seaport Therapeutics t…
www.seaporttx.com4 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-07-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-06-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-08 | -3.88 | -10.34 | ✗ Miss |
Companies in the same industry, via Finnhub
RSI (14-day)
49.3
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.63
Bearish momentumMACD below its signal line (0.78).
50-day average
18.16
Price aboveShort-term trend reference.
Daily values · indicators are descriptive, not trading advice